These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 34922323)

  • 61. Evaluation of 5-fluorouracil metabolic enzymes as predictors of response to adjuvant chemotherapy outcomes in patients with stage II/III colorectal cancer: a decision-curve analysis.
    Shigeta K; Ishii Y; Hasegawa H; Okabayashi K; Kitagawa Y
    World J Surg; 2014 Dec; 38(12):3248-56. PubMed ID: 25167895
    [TBL] [Abstract][Full Text] [Related]  

  • 62. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs.
    Zhao Y; Li Y; Sheng J; Wu F; Li K; Huang R; Wang X; Jiao T; Guan X; Lu Y; Chen X; Luo Z; Zhou Y; Hu H; Liu W; Du B; Miao S; Cai J; Wang L; Zhao H; Ying J; Bi X; Song W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):379. PubMed ID: 31455383
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma.
    Zhang Q; Ning G; Jiang H; Huang Y; Piao J; Chen Z; Tan X; Zhang J; Liu G
    Dis Markers; 2020; 2020():9180732. PubMed ID: 33520012
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An Individualized EMT-Related Gene Signature to Predict Recurrence-Free Survival in Stage II/III Colorectal Cancer Patients.
    Zhang W; Zhang X; Zhao D; Hu M; Ge X; Xia L
    Dig Dis Sci; 2022 Nov; 67(11):5116-5126. PubMed ID: 35094253
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
    Li X; Wang F; Sun Y; Fan Q; Cui G
    Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of lnc RNAs Related to Prognosis of Patients With Colorectal Cancer.
    Sun Y; Peng P; He L; Gao X
    Technol Cancer Res Treat; 2020; 19():1533033820962120. PubMed ID: 33111631
    [TBL] [Abstract][Full Text] [Related]  

  • 67. LncRNA signature in colorectal cancer.
    Ghafouri-Fard S; Hussen BM; Gharebaghi A; Eghtedarian R; Taheri M
    Pathol Res Pract; 2021 Jun; 222():153432. PubMed ID: 33857856
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.
    Zhou M; Zhang Z; Zhao H; Bao S; Sun J
    BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of an exosomal long non-coding RNAs panel for predicting recurrence risk in patients with colorectal cancer.
    Zhang Y; Liu H; Liu X; Guo Y; Wang Y; Dai Y; Zhuo J; Wu B; Wang H; Zhang X
    Aging (Albany NY); 2020 Apr; 12(7):6067-6088. PubMed ID: 32246818
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer.
    Tsai KW; Lo YH; Liu H; Yeh CY; Chen YZ; Hsu CW; Chen WS; Wang JH
    Mol Cancer; 2018 Mar; 17(1):72. PubMed ID: 29523145
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
    Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
    Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H
    Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Integrated analysis of long non-coding RNAs in human colorectal cancer.
    Chen X; Liu B; Yang R; Guo Y; Li F; Wang L; Hu H
    Oncotarget; 2016 Apr; 7(17):23897-908. PubMed ID: 27004403
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy.
    Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    BMC Cancer; 2019 May; 19(1):421. PubMed ID: 31060539
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients.
    Shi M; Beauchamp RD; Zhang B
    PLoS One; 2012; 7(7):e41292. PubMed ID: 22844451
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Artificial intelligence-driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi-center integration analysis.
    Xu H; Liu Z; Weng S; Dang Q; Ge X; Zhang Y; Ren Y; Xing Z; Chen S; Zhou Y; Ren J; Han X
    Mol Oncol; 2022 Dec; 16(22):4023-4042. PubMed ID: 36083778
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
    Wang XJ; Zeng B; Lin S; Chen M; Chi P
    Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multi-center evaluation of machine learning-based radiomic model in predicting disease free survival and adjuvant chemotherapy benefit in stage II colorectal cancer patients.
    Zhu H; Hu M; Ma Y; Yao X; Lin X; Li M; Li Y; Wu Z; Shi D; Tong T; Chen H
    Cancer Imaging; 2023 Aug; 23(1):74. PubMed ID: 37537659
    [TBL] [Abstract][Full Text] [Related]  

  • 80. FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms.
    Lu W; Fu D; Kong X; Huang Z; Hwang M; Zhu Y; Chen L; Jiang K; Li X; Wu Y; Li J; Yuan Y; Ding K
    Cancer Med; 2020 Feb; 9(4):1419-1429. PubMed ID: 31893575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.